Study: Cutaneous leishmaniasis responds to simple wound care

05/14/2013 | Healio

Cutaneous leishmaniasis may be best treated with local therapy and simple wound care instead of potentially toxic systemic treatments, according to a study published in Clinical Infectious Diseases. The researchers found that 92% of patients treated with simple wound care had positive outcomes after 42 and 60 days, compared with 79% of patients treated with cryotherapy and intralesional antimony injections, and 60% of patients who received systemic therapy.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Food Lawyer
Cargill
Wayzata, MN